Trade Bayer ^BAYGn

Mid North farmers update with latest cropping insights

Representative: Lawmakers Have 'Concerns' on Pesticide Immunity Bill

Bayer Pharma to expand cardiology, women's health portfolios with new drugs this year - Healthcare News | The Financial Express

Bayer to issue first carbon credits from regenerative farming practices in India | Valuespectrum.com

Two-year nighttime blood pressure changes after radiofrequency renal denervation: pooled results from the SPYRAL HTN trials

Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2024 Earnings Call Transcript

'Always new twists': Bayer legal team on defending a $4bn drug

Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism

Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trial

Bayer ordered to pay $2.1 billion in Roundup cancer lawsuit

Asian rise: AI-driven transformation, digital economies, path to net-zero

Times NOW Asian Business Leaders Conclave 2025 explores AI-driven transformation, digital economies, path to net-zero, ET Government

Hybrid Seeds Market Growth From USD 24.14 Billion in 2022 to an 11.0% CAGR by 2032 | Taiwan News | Mar. 27, 2025 06:02

Expanding access to dialysis coverage in Mexico

Farmer Benefits of Planting DEKALB® Brand Products - Brownfield Ag News

DAX Moderately Lower In Cautious Trade

Enzalutamide in patients with high-risk biochemically recurrent prostate cancer according to the European Association of Urology definition: a post hoc analysis of EMBARK

Research articles | Nature Communications

Bayer loses Georgia Roundup case

Business NewsLine, March 25, 2025

ACC.25: Bayer Presents New Investigational Heart Failure Data and Continued Portfolio Research in Chronic Kidney Disease in Type 2 Diabetes | Morningstar

DAX Advances On Positive Business Data

Doritos Crash The Super Bowl; Carat on Culture Measurement; Assembly on Authenticity; HubSpot on AI's Agility; Bayer on Engaging Social Video 03/25/2025

Bayer told to pay almost $2.1bn over Roundup cancer link claim

Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial

Bayer Faces $2 Billion Verdict Over Monsanto's Glyphosate Herbic

Georgia jury orders Monsanto parent to pay nearly $2.1 billion in Roundup weedkiller lawsuit

Roundup Weedkiller Verdict: Georgia Jury Orders Bayer To Pay $2 Billion

Monsanto parent company ordered to pay $2.1B in Roundup weedkiller lawsuit | Fox Business

Bayer ordered to pay €1.9 billion by US court in Roundup cancer case | Euronews

Dr. Mike Graham Appointed as New Head of R&D for Bayer's Crop Science Division | Morningstar

News Highlights: Top Company News of the Day - Monday at 5 AM ET | Morningstar

Hort movers: Bayer, Natural England, GreenMech

HEALTHCARE: Bayer (BAYNGR: Baa2 neg/BBB/BBB): $2.1bn Lawsuit Loss

Prompt initiation of durvalumab and tremelimumab for unresectable hepatocellular carcinoma in patients with chronic active hepatitis B: a phase 2 clinical trial

Bayer ordered by Georgia, US jury to pay $2.1B over Roundup, Bloomberg says | Markets Insider

Man who claimed Roundup weedkiller gave him cancer wins $2.1bn compensation

Bayer ordered to pay $2 billion in Roundup verdict - The Washington Post

US state orders Bayer to pay $2 billion in Roundup cancer case

Bayer hit with $3.3b Roundup verdict in US cancer case | Seymour Telegraph

Bayer hit with $2bn Roundup verdict

Bayer hit with $2 bln Roundup verdict in US state of Georgia cancer case

Planet Labs PBC (NYSE:PL) Q4 2025 Earnings Call Transcript

Bayer Hit With $2 Billion Roundup Verdict in US State of Georgia

Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLC

Northern Trust Corp (NTRS) Partners with Bayer for Digital Carbon Credit Management

FDA Approves Novartis Drug for Rare Kidney Disease Treatment - March 21, 2025 - Zacks.com

Is Bayer (BAYRY) Stock Undervalued Right Now? - March 20, 2025 - Zacks.com

Thyssenkrupp Names Axel Hamann CFO From May 1 (1)

Buy Ami Organics, target price Rs 2,605: JM Financial

Bayer's sNDA for Kerendia Label Expansion Gets FDA's Priority Review - March 18, 2025 - Zacks.com

Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors - Health Care Roundup | Morningstar

Legislation Looks to Limit Crop Protection Lawsuits

Bayer Gets Speedy FDA Review of Kerendia in Heart Failure | Morningstar

Bayer's Near-Term Outlook Dominated by Generic Pressures and Crop Science Uncertainty | Morningstar

| Agri-Pulse Communications, Inc.

Bayer wins Brazil injunction in soy patent row with farmers

Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials

Arson investigation under after fire at Bayer executive's home - CBS New York

State legislatures weigh bills to limit pesticide litigation

U.S. Egg Prices Hit New High: Near $6/Dozen | PressReleasePoint

The chemical takeover: How Big Ag is pushing to flood food with more toxins - and silence warnings - NaturalNews.com

Bayer treatment of NSCLC granted orphan designation | Markets Insider

Bayer price target raised to EUR 26 from EUR 22 at Berenberg | Markets Insider

Goldman Sachs Sticks to Its Hold Rating for Bayer (0P6S) | Markets Insider

Evogene Ltd. (NASDAQ:EVGN) Q4 2024 Earnings Call Transcript

Glenmark launches Polyethylene Glycol 3350, Powder for Solution in US - The Hindu BusinessLine

Glenmark launches Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC) | Capital Market News - Business Standard

Bayer Cropsc. Share Price Today, Bayer Cropsc. Stock Price Live NSE/BSE, Share Price Insights

Bayer to Seek Shareholder Approval to Issue Shares Toward U.S. Litigation if Needed | Morningstar

Bayer Weighs Billions in Capital Raise, Sending Shares Tumbling

Bayer could stop selling Roundup weedkiller over legal risks, Reuters says | Markets Insider

HEALTHCARE: Bayer (BAYNGR: Baa2 neg / BBB/BBB): New Equity Issuance

Bayer Seeks Approval for Capital Raise to Deal With Legal Woes

Radioligand Therapy Market Growth Driven by Increasing Cancer Prevalence and Advancements in Precision Medicine

Bayer (0P6S) Receives a Hold from Kepler Capital | Markets Insider

Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trial

Pharma Stock Roundup: BAYRY's Q4 Results, ABBV's Obesity Deal & More - March 7, 2025 - Zacks.com

Bayer's foliar fungicides offer enhanced disease protection

New Bayer herbicide to combat tough to control weeds - Brownfield Ag News

UBS Remains a Hold on Bayer (0P6S) | Markets Insider

Bayer Earnings: Challenges Continue as Management Guides for a Difficult 2025 | Morningstar

Bayer doubles down on commitment to China pharmacare - Chinadaily.com.cn

Meta-analysis of genome-wide associations and polygenic risk prediction for atrial fibrillation in more than 180,000 cases

Bayer's state-level power play: Undermining MAHA and shielding glyphosate from accountability - NaturalNews.com

Bayer sees FY25 sales roughly at prior-year level | Markets Insider

J.P. Morgan Sticks to Their Hold Rating for Bayer (0P6S) | Markets Insider

Bayer champions sustainability for Pakistan's future

Bayer Stock Up On Growth View Starting FY26, Despite Q4 Loss, Cautious FY25

News Highlights: Top Company News of the Day - Wednesday at 3 AM ET | Morningstar